ICMR has
signed an MoU with the IVI for vaccine
The Indian Council of
Medical Research (ICMR) has signed an MoU with the International Vaccine
Institute (IVI) for collaborating on vaccine research and development.
The MoU was signed between
Soumya Swaminathan, the Director General of ICMR and Secretary, Department of
Health Research, Manoj Jhalani, Additional Secretary and managing director,
National Health Mission, and IVI Director General Jerome H. Kim.
IVI has been partnering with
Indian vaccine manufacturers, research institutes, government, and public
health agencies on vaccine development, research, and training. One of the most
successful collaborations was with Shantha Biotech on the development of
Shanchol, the world’s first low-cost oral cholera vaccine.
The vaccine was licensed in
India in 2009 and WHO-prequalified in 2011.
India is a vaccine industry
powerhouse that supplies 60% of the world’s vaccines. The signing of the MoU is
a continuation of our partnership with India to provide safe, effective and
affordable vaccines for people around the world.
ટિપ્પણીઓ નથી:
ટિપ્પણી પોસ્ટ કરો